DNA sequences, recombinant DNA molecules and processes for producing human phospholipase inhibitor polypeptides
US4879224A · kind A · utility
24Cited by
4References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 10, 1985 |
| Grant date | Nov 7, 1989 |
| Priority date | — |
| Expiry date | Jan 10, 2005 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
DNA sequences, recombinant DNA molecules and hosts transformed with them which produce human phospholipase inhibitor polypeptides and methods of making and using these products. The DNA sequences and recombinant DNA molecules are characterized in that they code on expression for a human phospholipase inhibitor polypeptide. In appropiate hosts these DNA sequences permit the production of human phospholipase inhibitor polypeptides.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.